| ASSET | QUARTER | % RETURN |
|---|---|---|
TG Therapeutics (TGTX) | Q1 2017 | 142.71% |
Freedom (FRHC) | Q1 2017 | 127.27% |
Zurn Elkay Water Solutions (ZWS) | Q1 2017 | 126.17% |
Catalyst Pharmaceuticals (CPRX) | Q1 2017 | 87.5% |
Chemours (CC) | Q1 2017 | 78.48% |
Light & Wonder (LNW) | Q1 2017 | 65.96% |
National Beverage (FIZZ) | Q1 2017 | 65.45% |
Option Care Health (OPCH) | Q1 2017 | 55.96% |
Celsius (CELH) | Q1 2017 | 54.76% |
Transportadora de Gas del Sur SA ADR (TGS) | Q1 2017 | 52.9% |
Corcept Therapeutics (CORT) | Q1 2017 | 50.34% |
RH (RH) | Q1 2017 | 50.19% |
TAL Education (TAL) | Q1 2017 | 50.1% |
Universal Display (OLED) | Q1 2017 | 50.05% |
Extreme Networks (EXTR) | Q1 2017 | 48.71% |
Glaukos (GKOS) | Q1 2017 | 47.33% |
Pampa Energia SA ADR (PAM) | Q1 2017 | 46.54% |
Energy of Minas Gerais Co DRC (CIG.C) | Q1 2017 | 45.35% |
Lantheus (LNTH) | Q1 2017 | 44.51% |
Exelixis (EXEL) | Q1 2017 | 43.13% |
New Oriental Education & Technology (EDU) | Q1 2017 | 41.24% |
Blueprint Medicines (BPMC) | Q1 2017 | 41.16% |
Nova (NVMI) | Q1 2017 | 40.94% |
CleanSpark (CLSK) | Q1 2017 | 40.85% |
HUTCHMED DRC (HCM) | Q1 2017 | 40.49% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
